NAFDAC HAS DISCONTINUED REGISTRATION OF MULTI-DOSE ARTEMETHER /LUMEFANTRINE DRY POWDER FOR ORAL SUSPENSION
NAFDAC HAS DISCONTINUED REGISTRATION OF MULTI-DOSE ARTEMETHER /LUMEFANTRINE DRY POWDER FOR ORAL SUSPENSION The National Agency for Food and Drug Administration and Control (NAFDAC) would like to inform the public that it has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. This decision was made due to the instability of the…
